Skip to main content

Advertisement

SpringerLink
Log in

An Analysis of Content in Comprehensive Cancer Control Plans that Address Chronic Hepatitis B and C Virus Infections as Major Risk Factors for Liver Cancer

  • Review
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

Chronic hepatitis B and hepatitis C virus (HBV and HCV) infections are among the leading causes of preventable death worldwide. Chronic viral hepatitis is the cause of most primary liver cancer, which is the third leading cause of cancer deaths globally and the ninth leading cause of cancer deaths in the United States. The extent to which comprehensive cancer control (CCC) programs in states, tribal governments and organizations, territories, and Pacific Island jurisdictions address chronic hepatitis B and/or hepatitis C infections as risk factors for liver cancer or recommend interventions for liver cancer prevention in their CCC plans remains unknown. We searched CCC plans for this information using the search tool at http://www.cdc.gov/cancer/ncccp/ to access the content of plans for this information. A combination of key search terms including “liver cancer”, “hepatitis”, “chronic alcohol”, and “alcohol abuse” were used to identify potential content regarding liver cancer risk factors and prevention. Relevant content was abstracted for further review and classification. Of 66 (Although CDC funds 65 programs, one of the Pacific Island Jurisdiction grantees is the Federated States of Micronesia (FSM). This national program supports four FSM states, each of which submits a cancer plan to CDC for a total of 69 plans. During this time period, 66 plans were available on the website.) CCC plans, 27% (n = 18) addressed liver cancer using the above-mentioned search terms. In the 23 plans that addressed HBV and/or HCV, there were 25 goals, objectives, strategies, and outcomes aimed at reducing the incidence or prevalence of HBV and/or HCV infection. While nearly a third of CCC programs identify at least one goal, objective, strategy, outcome, or prevention program to reduce cancer burden in their CCC plans, few plans discuss specific actions needed to reduce the burden of liver cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Centers for Disease Control, Prevention. (2010). Hepatocellular carcinoma, United States, 2001–2006. MMWR. Morbidity and Mortality Weekly Report, 59(17), 517–520.

    Google Scholar 

  2. Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009). Hepatocellular carcinoma incidence, mortality, survival trends in the United States from 1975 to 2005. Journal of Clinical Oncology, 27(9), 1485–1491.

    Article  PubMed  Google Scholar 

  3. Colvin, H. M., & Mitchell, A. E. (Eds.). (2010). Hepatitis and liver cancer: A national strategy for prevention and control of hepatitis B and C. Committee on the Prevention and Control of Viral Hepatitis Infections, Institute of Medicine. Available at: http://www.nap.edu. Accessed September 30, 2011.

  4. Centers for Disease Control and Prevention. (2011). Disease burden from hepatitis A, B, and C in the United States. Available at: http://www.cdc.gov/hepatitis/Statistics/index.htm. Accessed September 30, 2011.

  5. Given, L. S., Black, B., Lowry, G., Huang, P., & Kerner, J. F. (2005). Collaborating to conquer cancer: A comprehensive approach to cancer control. Cancer Causes and Control, 16(Suppl 1), 3–14.

    PubMed  Google Scholar 

  6. Centers for Disease Control and Prevention. (2011). National comprehensive cancer control program. Available at: http://www.cdc.gov/Cancer/ncccp/. Accessed September 30, 2011.

  7. Perz, J. F., Armstrong, G. L., Farrington, L. A., Hutin, Y. J., & Bell, B. P. (2006). The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology, 45(4), 529–538.

    Article  PubMed  Google Scholar 

  8. Vong, S., & Bell, B. P. (2004). Chronic liver disease mortality in the United States, 1990–1998. Hepatology, 39(2), 476–483.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cancer Prevention and Control, Centers for Disease Prevention and Control, 4770 Buford Highway, MS K-57, Atlanta, GA, 30341, USA

    Behnoosh Momin & Lisa Richardson

Authors
  1. Behnoosh Momin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lisa Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Behnoosh Momin.

Additional information

Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Momin, B., Richardson, L. An Analysis of Content in Comprehensive Cancer Control Plans that Address Chronic Hepatitis B and C Virus Infections as Major Risk Factors for Liver Cancer. J Community Health 37, 912–916 (2012). https://doi.org/10.1007/s10900-011-9507-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-011-9507-y

Keywords

Search

Navigation